The "other" invisible Lyme disease- Borrelia miyamotoi- now has its own test, thanks to IGeneX!
This can be especially important for those who test negative on other Lyme tests. A recent study showed animals being tested had Borrelia miyamotoi twice as often as Borrelia burgdorferi.
Who'd have thought?
As far as I know, there are no commercial tests for this strain that have been developed for the public, though Yale has been sucking up the money for its research for at least a decade!
This strain is found in the US and a number of other countries too, so my guess is rather than focusing on getting the word out and helping patients, Yale's research is trying to develop and patent their own tests and later a vaccine.
Funny, there were almost 40 new studies on this strain just in 2014. Another potential cash cow for whoever can get a test on the market first.
But then what do I know? ~smile~
Please feel free to share the info below. And thanks for doing so.
Great! 'Cause we've been hearing for a while that there was only a lab test for ticks but no public test for miyamotoi.
So I would assume that the www.lymetap.com 75%-off discount for IGeneX testing for low-income folks will apply to this new one too.
Posted by Sammi (Member # 110) on :
Tincup, thanks for posting this. It is great news!
Posted by Lymetoo (Member # 743) on :
Good deal!
Posted by blinkie1 (Member # 42790) on :
So you know that the big labs will have one hot on their tails. They can't let Igenex use this as a catalyst for legitimacy. If they are the only lab that has a test, doctors might actually start believing in them. They can't let that happen. 😉
Posted by Tincup (Member # 5829) on :
Blinkie- I'm afraid you are right! The bad boys are working frantically to do what appears to be setting up enough studies (right or wrong) to apply for patents (if they haven't already) and or vaccine rights.
Sad, sad, sad!!!!
Posted by LisaK (Member # 41384) on :
sharing
_
Posted by miyamotoi (Member # 41833) on :
Actually, Dr Lee at Milford Hospital has been offering a PCR plus sequencing test that will catch all genospecies of Borrelia including b. miyamotoi for about a year.
The California Department of Public Health has been testing ticks for Bm for about 10 years. They and others have finally released research showing Bm is just as prevalent as Bb in California. In some areas, its actually higher and by the way, the CDC 2 tiered test WILL NOT catch Bm. So if you live in CA and been tested negative or equivocal, it might be wise to check if its B miyamotoi or one of a couple other genospecies now found in CA like B. bisettii.
The CDC 2 tiered test is quite genotype sensitive so if you have genotype or genospecies not closely related to the CT based B31, the test can and does fail. This is not its only problem but one worth keeping an eye on while being diagnosed especially outside the North East.
![[Big Grin]](biggrin.gif)